Clinical Trial: Study to Evaluate Efficacy and Safety of Gyntima(R) Balance in Preventing Recurrences of Bacterial Vaginosis

U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07527572) titled 'Study to Evaluate Efficacy and Safety of Gyntima(R) Balance in Preventing Recurrences of Bacterial Vaginosis' on March 25.

Brief Summary: The vagina is a dynamic muscular organ whose health relies on a Lactobacillus-dominant microbiota that maintains low pH and protects against infections. Bacterial vaginosis (BV) is the most common vaginal imbalance in women of reproductive age, caused by depletion of protective Lactobacillus species and overgrowth of anaerobic bacteria such as Gardnerella vaginalis. BV affects an estimated 23-29 percentage of women globally (10-30 percentage in India) and is associated with discharge, odor, disco...